Inovalon Holdings, Inc. - (INOV): Price and Financial Metrics

Inovalon Holdings, Inc. - (INOV)

Today's Latest Price: $26.57 USD

0.32 (1.22%)

Updated Sep 30 12:25pm

Add INOV to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

INOV Stock Summary

  • INOV's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 839.83 -- higher than 96.11% of US-listed equities with positive expected earnings growth.
  • With a price/earnings ratio of 355.38, Inovalon Holdings Inc P/E ratio is greater than that of about 97.85% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Inovalon Holdings Inc is higher than 88.12% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Inovalon Holdings Inc are CUB, ORBC, SPB, CE, and SYNH.
  • INOV's SEC filings can be seen here. And to visit Inovalon Holdings Inc's official web site, go to
INOV Daily Price Range
INOV 52-Week Price Range

INOV Stock Price Chart Technical Analysis Charts

INOV Price/Volume Stats

Current price $26.57 52-week high $26.96
Prev. close $26.25 52-week low $13.39
Day low $26.22 Volume 113,863
Day high $26.66 Avg. volume 487,967
50-day MA $24.54 Dividend yield N/A
200-day MA $19.98 Market Cap 4.13B

Inovalon Holdings, Inc. - (INOV) Company Bio

Inovalon Holdings provides advanced cloud-based data analytics and data-driven intervention platforms to the healthcare industry in the United States. The company was founded in 1998 and is based in Bowie, Maryland.

INOV Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$26.57$2.73 -90%

Below please find a table outlining a discounted cash flow forecast for INOV, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Inovalon Holdings Inc ranked in the 11th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 89.67%. The most interesting components of our discounted cash flow analysis for Inovalon Holdings Inc ended up being:

  • Its compound free cash flow growth rate, as measured over the past 5.33 years, is -0.01% -- higher than only 24.37% of stocks in our DCF forecasting set.
  • Inovalon Holdings Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 9. This value is greater than 73.42% stocks in the Technology sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as INOV, try EVOP, INIS, ITRI, SPOT, and TTD.

INOV Latest News Stream

Event/Time News Detail
Loading, please wait...

INOV Latest Social Stream

Loading social stream, please wait...

View Full INOV Social Stream

Latest INOV News From Around the Web

Below are the latest news stories about Inovalon Holdings Inc that investors may wish to consider to help them evaluate INOV as an investment opportunity.

Inovalon (INOV) Investor Presentation - Slideshow

The following slide deck was published by Inovalon Holdings, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | August 25, 2020

Inovalon Holdings: Resilient Growth Within Healthcare

Investors do not wait. Get ready for Active Management now! Now is the time for investors to incorporate quantitative tools to empower their portfolio management. Any change in the direction of any of the principal components of earnings growth such as sales growth, gross margins, operating or financing costs, may be important indicators about future direction […] The post Inovalon Holdings: Resilient Growth Within Healthcare appeared first on ValueWalk .

ValueWalk | August 18, 2020

Inovalon Holdings, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Inovalon Holdings, Inc. in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | July 30, 2020

Should Inovalon Holdings, Inc. (NASDAQ:INOV) Focus On Improving This Fundamental Metric?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Yahoo | July 23, 2020

Inovalon ONE® Platform Selected by Walmart

Retailer’s Specialty Pharmacy Business to Implement ScriptMed® Cloud Solution to Empower Enhanced Outcomes and Economics for its CustomersBOWIE, Md., July 23, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a long-term engagement with Walmart’s Specialty Pharmacy business (NYSE: WMT) to provide cloud-based capabilities through the Inovalon ONE® Platform as part of its data-driven strategy to improve outcomes and economics for its customers. The high-complexity and high-cost nature of specialty pharmacy stands to benefit significantly from the capabilities enabled through the Inovalon ONE® Platform. Through the implementation of ScriptMed® Cloud, a software-as-a-service (SaaS) cloud offering...

Yahoo | July 23, 2020

Read More 'INOV' Stories Here

INOV Price Returns

1-mo 7.38%
3-mo 34.87%
6-mo 70.54%
1-year 66.37%
3-year 55.84%
5-year 28.79%
YTD 41.18%
2019 32.72%
2018 -5.47%
2017 45.63%
2016 -39.41%
2015 N/A

Continue Researching INOV

Want to see what other sources are saying about Inovalon Holdings Inc's financials and stock price? Try the links below:

Inovalon Holdings Inc (INOV) Stock Price | Nasdaq
Inovalon Holdings Inc (INOV) Stock Quote, History and News - Yahoo Finance
Inovalon Holdings Inc (INOV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7435 seconds.